The Atriva Management

Rainer Lichtenberger, Ph.D. MBA

More than 30 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 16 years CEO/COO experience in several SME, raised ÔéČ 80 Mn venture funds.

Read more

Christian Wallasch, Ph.D.

Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.

Read more

Stephan Stenglein, M.D.

Physician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.

Read more

Prof. Oliver Planz, Ph.D.

Universit├Ąt D-T├╝bingen, Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

Read more

Bj├Ârn Cochlovius, Ph.D., Assoc. Prof.
VP Business Development

20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing.

Read more